Advertisement
No access
Reports

Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever Virus

Science
11 Dec 1998
Vol 282, Issue 5396
pp. 2079-2081

Abstract

A peripheral membrane protein that is interactive with lymphocytic choriomeningitis virus (LCMV) was purified from cells permissive to infection. Tryptic peptides from this protein were determined to be α-dystroglycan (α-DG). Several strains of LCMV and other arenaviruses, including Lassa fever virus (LFV), Oliveros, and Mobala, bound to purified α-DG protein. Soluble α-DG blocked both LCMV and LFV infection. Cells bearing a null mutation of the gene encoding DG were resistant to LCMV infection, and reconstitution of DG expression in null mutant cells restored susceptibility to LCMV infection. Thus, α-DG is a cellular receptor for both LCMV and LFV.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES AND NOTES

1
C. Peters, M. Buchmeier, P. Rollin, T. Ksiazek, in Fields Virology, B. Fields, Ed. (Lippincott-Raven, Philadelphia, 1996), vol. 2, pp. 1521–1551.
2
Fabiyi A., Bull. Pan Am. Health Organ. 10, 335 (1976);
Salas R., et al., Lancet 338, 1033 (1991).
3
Frame J., Baldwin J. J., Gocke D., Troup J., Am. J. Trop. Med. Hyg. 19, 670 (1970);
McCormick J., Webb P., Krebs J., Johnson K., Smith E., J. Infect. Dis. 155, 437 (1987).
4
P. Borrow and M. B. A. Oldstone, in Viral Pathogenesis, N. Nathanson, Ed. (Lippincott-Raven, Philadelphia, 1997), pp. 593–627;
Zinkernagel R. M., Science 271, 173 (1996);
; Scand. J. Immunol.46, 421 (1997);
Oldstone B. A., Fujinami R. S., Lampert P. W., Prog. Med. Virol. 26, 45 (1980);
Rowe W. P., Nav. Med. Res. Inst. Rev. Rep. 12, 167 (1954) .
5
Borrow P., Oldstone M., J. Virol. 66, 7270 (1992).
6
Burns J., Buchmeier M., Virology 183, 620 (1991).
7
Modified from (5). A goat antibody to mouse immunoglobulin G (anti-mouse IgG) conjugated with horseradish peroxidase (Pierce) [1:5000 dilution in phosphate-buffered saline (PBS)] was used to substitute rabbit anti-mouse IgG and I125–protein A. Afterward, an enhanced chemiluminescence assay was performed with the SuperSignal Chemiluminescent substrate (Pierce).
8
Monolayers of MC57 cells were dissociated with PBS and 5 mM EDTA. Cells were solubilized in a buffer containing 20 mM tris (pH 7.4), 0.15 M NaCl, 1.5% octyl-glucoside, 0.5 mM phenylmethylsulfonyl fluoride, and 1× Complete protease inhibitor cocktail (Boehringer Mannheim) for 60 min on ice. The sample was then spun for 15 min at 2500g, and the supernatant was centrifuged again for 60 min at 100,000g at 4°C. The cleared sample was loaded onto a Mono Q HR5/5 column (Pharmacia) and eluted with 1 M NaCl. Aliquots of the protein fractions were separated by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) on 6% polyacrylamide gels for VOPBA analysis to locate the fractions enriched for LCMV-binding activity. The peak fractions were combined and passed through a 10-ml lentil-Sepharose column that did not retain the putative receptor of LCMV. Flow-through material was then loaded directly onto a 10-ml wheat germ agglutinin–Sepharose column, from which the protein was eluted with 0.5 M N-acetylglucosamine. Subsequently, VOPBA-positive fractions were combined and put through a 5-ml jacalin-Sepharose column. After the column was washed with 0.2 M melibiose, 1 M NaCl, 3 M KSCN, and 1% SDS to remove contaminating proteins, the whole column was disrupted and the Sepharose was boiled in SDS sample buffer with 2.5% β-mercaptoethanol for 5 min. The denatured sample was then concentrated fivefold by UltraFree-MC centricons (MilliPore) before resolved on a 6% SDS-polyacrylamide gel.
9
The Coomassie blue–stained protein band with VOPBA binding activity was excised from the SDS-polyacrylamide gel and submitted for peptide sequencing analysis. After in-gel digestion with trypsin, the sequences of five peptides were determined at the Harvard Microchemistry Facility by collisionally activated dissociation on a Finnigan TSQ7000 Triple Quadrupole Mass Spectrometer. GT384 (AGDPAPVVNDIHK) (24), GT441 (GGLSAVDAFEIHVHK), and GT417 (IPSDTFYDNEDTTTDKLK) were homologous to regions of DG precursor. GT429 (AFDDGAFTGIR) was homologous to amino acids 3 to 13 of jacalin and GT348 (KLERKLREK) to amino acids 31 to 39 of U1 small nuclear ribonucleoprotein.
10
Ibraghimov-Beskrovnaya O., et al., Nature 355, 696 (1992).
11
Henry M., Campbell K., Curr. Opin. Cell Biol. 8, 625 (1996).
12
Durbeej M., Henry M., Ferletta M., Campbell K., Ekblom P., J. Histochem. Cytochem. 46, 449 (1998).
13
Williamson R., et al., Hum. Mol. Genet. 6, 831 (1997).
14
P. Borrow, E. V. Ravkov, C. J. Peters, M. B. A. Oldstone, S. T. Nichol, in preparation.
15
Yamada H., et al., J. Neurochem. 66, 1518 (1996).
16
The α2 subunit of the dihdropyridine receptor complex was purified from rabbit skeletal muscle as described in
Jay S. D., et al., J. Biol. Chem. 266, 3287 (1991).
17
W. Cao et al., unpublished results.
18
We plated 1 × 105 of 3T6 cells per well into a 24-well plate the day before the experiment. Aliquots of 1.6 × 105 plaque-forming units of LCMV strain Cl 13 and VSV Indiana strain were incubated for 20 min on ice with either bovine serum albumin (BSA) or purified α-DG protein from rabbit skeletal muscle at concentrations of 0, 9 pM, 90 pM, 0.9 nM, 9 nM, and 90 nM in a final volume of 150 μl. One aliquot of treated virus was then incubated with cells for 30 min at 37°C before being replaced with fresh growth medium. Sixteen hours later, virus titers from culture supernatant were determined by plaque assay on Vero cells. Cells were fixed with acetone and analyzed by immunofluorescence staining with a monoclonal antibody (mAb) 1-1-3 to detect LCMV nucleoprotein or mAb I1 to detect VSV glycoprotein. A fluorescein isothiocyanate–conjugated goat anti-mouse IgG diluted 1:20 with PBS was used as the secondary antibody in the staining.
19
M. D. Henry and K. P. Campbell, Cell, in press. Briefly, DG−/− ES cells were isolated from two independently derived parental DG+/− ES cell clones TD354 and TD556 generated during the initial DG gene targeting effort by selection with active G418 (1.0 mg/ml). Surviving clones were analyzed by Southern (DNA) blot with a Hind III–Pst I fragment from intron 1 of the mouse DG gene as a probe. The DG adenovirus was constructed by subcloning a rabbit cDNA into the pAdRSVpA shuttle vector and then incorporated into an adenovirus vector through standard methods of homologous recombination. The loss of DG protein expression in clones exhibiting homozygous loss of the wild-type DG allele and expression of DG in DG null cells as a result of adenovirus infection were confirmed by protein immunoblot and immunofluorescence analysis.
20
We plated 2 × 105 of ES cells per well into a 24-well plate the day before 2 × 109 adenovirus particles carrying rabbit DG cDNA (estimated MOI of 5) was added in the culture medium. Two days later, aliquots of LCMV Cl 13 virus in 200 μl were added to each well. After incubation for 45 min at 37°C, the inoculum was replaced by 1 ml of fresh ES growth medium. Sixteen hours later, cells were fixed with acetone and immunostained with mAb 1-1-3 to detect the LCMV nucleoprotein.
21
J. Clegg, in The Arenaviridae, M. Salvato, Ed. (Plenum, New York, 1993), pp. 175–185.
22
Bowen M., Peters C., Nichol S., Virology 219, 285 (1996).
23
Fazakerley J., Southern P., Bloom F., Buchmeier M., J. Gen. Virol. 72, 1611 (1991).
24
Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
25
We thank W. Lane at Harvard Microchemistry facility for peptide sequencing; Y. Lu and H. Lewicki for technical assistance; J. C. de la Torre, M. Manchester, and J. Paulson for experimental advice and consultation; and J. C. de la Torre, M. Manchester, D. Naniche, I. Novella, S. Huang, C. Evans, and C. Lebakken for helpful discussions and comments on the manuscript. Supported by a research grant AI 09484 for M.B.A.O. and a training grant AG 00080 for W.C. from the NIH. M.D.H. was supported by a National Research Service Award (DK09712) and by the Iowa Cardiovascular Research Fellowship (HL071221). H.Y. was supported by American Heart Association Fellowship (IA-97-FW-25) and by the Mizutani Foundation. K.P.C. is an investigator of the Howard Hughes Medical Institute.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 282 | Issue 5396
11 December 1998

Submission history

Received: 25 August 1998
Accepted: 4 November 1998
Published in print: 11 December 1998

Permissions

Request permissions for this article.

Authors

Affiliations

Wei Cao
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Michael D. Henry
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Persephone Borrow
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Hiroki Yamada
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
John H. Elder
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Eugene V. Ravkov
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Stuart T. Nichol
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Richard W. Compans
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Kevin P. Campbell
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.
Michael B. A. Oldstone*
W. Cao and M. B. A. Oldstone, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. M. D. Henry, H. Yamada, K. P. Campbell, Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, IA 52242, USA. P. Borrow, Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, UK. J. H. Elder, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E. V. Ravkov and R. W. Compans, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA. S. T. Nichol, Center for Disease Control, 1600 Clifton Road, NE, MSG14, Atlanta, GA 30333, USA.

Notes

*
To whom correspondence should be addressed. E-mail address: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus, Science Translational Medicine, 14, 668, (2022)./doi/10.1126/scitranslmed.abq0991
    Abstract
  2. A Welcome Mat for Leprosy and Lassa Fever, Science, 282, 5396, (1999-2000), (2021)./doi/10.1126/science.282.5396.1999
    Abstract
  3. Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry, Science, 340, 6131, (479-483), (2021)./doi/10.1126/science.1233675
    Abstract
  4. O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding, Science, 327, 5961, (88-92), (2021)./doi/10.1126/science.1180512
    Abstract
  5. Subversion of Schwann Cells and the Leper's Bell, Science, 296, 5569, (862-863), (2021)./doi/10.1126/science.1072444
    Abstract
  6. Lassa virus entry requires a trigger-induced receptor switch, Science, 344, 6191, (1506-1510), (2014)./doi/10.1126/science.1252480
    Abstract
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media